Clinical Rheumatology

, Volume 12, Issue 2, pp 274–277 | Cite as

Chronic destructive monoarthritis of the wrist in patients with anti-SSA/Ro antibodies: Report of two cases

  • M. Satoh
  • H. Yamagata
  • F. Watanabe
  • Y. Matsushita
  • S. Nakayama
  • K. Okubo
  • M. Akizuki
Case Report

Summary

Among 340 patients with rheumatic diseases, two cases of chronic destructive monoarthritis of the wrist with anti-SSA/Ro antibodies and rheumatoid factor, were observed for over three years. It is not clear whether these cases represent a specific subset of rheumatoid arthritis (RA) or whether they may progress to diffuse symmetrical destructive polyarthritis typical of RA. Long-term follow-up studies including analysis of autoantibodies will be needed to clarify the characteristics and course of chronic monoarthritis.

Key words

Monoarthritis Rheumatoid Arthritis Rheumatoid Factor Anti-SSA/Ro Antibodies Anti-Nuclear Antibodies 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Pitkeathly, D.A., Griffiths, H.E.D., Catto, M. Monoarthritis, A study of forty-five cases. J Bone Joint Surg 1964, 46B, 685–696.Google Scholar
  2. 2.
    Rasmussen, G., Reimann, I., Anderson, B. Monoarthritis, clinical and histological examination. Scand J Rheumatol 1973, 2, 65–69.PubMedGoogle Scholar
  3. 3.
    Fletcher, M.R., Scott, J.T. Chronic monoarticular synovitis. Diagnostic and prognostic features. Ann Rheum Dis 1975, 34, 171–176.PubMedGoogle Scholar
  4. 4.
    Kaarela, K., Tiitinen, S., Luukkainen, R. Long-term prognosis of monoarthritis. Scand J Rheumatol 1983, 12, 374–376.PubMedGoogle Scholar
  5. 5.
    Iguchi, T., Matsubara, T., Kawai, K., Hirohata, K. Clinical and histologic observations of monoarthritis. Anticipation of its progression to rheumatoid arthritis. Clin Orthop 1990, 250, 241–249.PubMedGoogle Scholar
  6. 6.
    Arnett, F.C., Edworthy, S.M., Bloch, D.A. et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31, 315–324.PubMedGoogle Scholar
  7. 7.
    Mountsopoulos, H.M., Skopouli, F.N., Sarras, A.K. et al. Anti-Ro(SSA) positive rheumatoid arthritis (RA): a clinicoserological group of patients with high incidence of D-penicillamine side effects. Ann Rheum Dis 1985, 44, 215–219.PubMedGoogle Scholar
  8. 8.
    Boire, G., Menard, H.A. Clinical significance of anti-Ro(SSA) antibody in rheumatoid arthritis. J Rheumatol 1988, 15, 391–394.PubMedGoogle Scholar
  9. 9.
    Skopouli, F.N. Andnopoulos, A.P., Mountsopoulos, H.M. Clinical implications of the presence of anti-Ro(SSA) antibodies in patients with rheumatoid arthritis. J Autoimmunity 1988, 3, 381–388.Google Scholar
  10. 10.
    Vlachoyianopoulos, P.G. Mountsopoulos H.M. Rheumatoid arthritis in southeast Europe. Baillieres Clin Rheumatol 1992, 6, 221–233.PubMedGoogle Scholar

Copyright information

© Clinical Rheumatology 1993

Authors and Affiliations

  • M. Satoh
    • 1
  • H. Yamagata
    • 1
  • F. Watanabe
    • 1
  • Y. Matsushita
    • 1
  • S. Nakayama
    • 1
  • K. Okubo
    • 2
  • M. Akizuki
    • 3
  1. 1.Department of Internal MedicineNational Murayama HospitalJapan
  2. 2.Department of Internal MedicineFussa HospitalJapan
  3. 3.Department of Internal MedicineKeio University School of MedicineTokyoJapan

Personalised recommendations